Texas just committed $110 million to develop ibogaine through FDA trials after a 15-month grassroots campaign. Rick Perry and W. Bryan Hubbard reveal how this psychedelic compound achieves 85-98% addiction recovery rates, reverses traumatic brain injury, and is now spreading to 13+ states despite 60 years of federal prohibition rooted in Nixon-era drug war politics. Ibogaine shows 85% opioid addiction recovery in 48-72 hours with one dose, compared to 18-month abstinence programs with single-digit success rates, and 98% with two doses. Perry's brain scans showed 27% prefrontal cortex increase one week after ibogaine treatment and complete reversal of brain atrophy by six months, suggesting neuroregeneration benefits for concussion and neurodegenerative disease.